CoreAge Rx’s current offer advertises $99 per month with no automatic billing. RespondWell lists a $180 first thirty-day order and $219 refills, while its RWell page also presents prepaid three- and six-month options. Those are different purchasing structures, not just different numbers.
We checked public pages on September 22, 2026, without completing checkout or testing care. CoreAge Rx is our disclosed featured commercial partner and receives first placement. That arrangement does not establish better medical outcomes or make either service appropriate for everyone.
Compare today’s payment and later obligations before comparing monthly equivalents.
What each published price represents
CoreAge's landing page describes a flat $99 offer including provider review, medication, supplies, and shipping. Those are advertised inclusions, not a verified invoice or a promise about every laboratory need. Confirm what your proposed care requires before paying.
RespondWell's RWell page shows $499 for three months and $649 for six months. Dividing the total by the term explains a monthly equivalent, but it does not make that amount available as a single-month purchase. Our cost guide helps compare like periods and included services.
Automatic billing changes the practical decision
CoreAge advertises an order-based offer without auto-billing. RespondWell's policy describes automatic refill arrangements, earlier processing dates, and cancellation deadlines. Turning off an upcoming refill is not necessarily enough to stop one already in fulfillment.
Ask each provider to identify the next payment event in your actual plan. For RespondWell, confirm the portal date and how the forty-eight-hour cancellation rule applies. The subscription guide explains why a delivery date and a cancellation deadline should be written down separately.
Clinical non-approval is different from changing your mind
CoreAge advertises an automatic refund when prescribing is declined. RespondWell also describes non-approval refunds, while its policy addresses deductions for incurred services and a consultation fee for certain successfully stopped orders after prescribing review.
Those scenarios are not interchangeable. Ask what happens if you are declined, voluntarily cancel, need additional tests, or later discontinue. Longer-term savings should be weighed with the relevant commitment, not treated as guaranteed savings regardless of clinical changes. Neither provider's public policy was tested through a purchase in this review.
Both services still need a suitable clinical assessment
A short intake and remote review can be convenient, but the important question is whether the clinician obtains enough information for your situation. Ask how existing conditions, other prescriptions, and relevant laboratory results are reviewed and when a live visit or outside assessment may be needed.
The prescriber guide addresses professional identity and state authority. A national marketing page does not establish that the assigned clinician can see you from any travel destination. Eligibility must be confirmed for the person and the appointment.
A price comparison cannot establish equivalent products
The ingredient name alone does not establish equal concentrations, quantities, excipients, storage instructions, or evidence. Ask for the actual prescription and pharmacy details instead of assuming both offers deliver identical medication because they use the word sermorelin.
FDA distinguishes compounded drugs from approved finished medicines. Neither a commercial recommendation nor a lower advertised amount proves clinical superiority. The clinical-studies guide explains why results involving another preparation, hormone treatment, or population should not be transferred automatically to either offer.
Choose the questions that would change your decision
For an order-based offer, clarify how repeat clinical review and later orders work. For a prepaid or recurring plan, clarify the total commitment and what happens to unfilled care after a medical change. For both, establish who handles questions after delivery.
Read the CoreAge Rx review and RespondWell review alongside this comparison. The better fit depends on clinical suitability and the care arrangement you can actually use, as well as the documented financial terms. Our featured placement is commercial, not a substitute for those checks.
Sources behind this article
Provider pages describe their own services. They are not independent proof of health outcomes. Pricing and availability can change.
- CoreAge Rx: Current sermorelin offerProvider primary source · Public redirect checked September 22, 2026. Landing page advertises $99 per month and no auto-billing; not a verified patient checkout.
- RWell by RespondWell: Sermorelin plansProvider primary source · Provider offer; prepaid monthly equivalents differ from one-month charges. Checked September 22, 2026.
- RWell: Billing and refundsProvider primary source · Public billing policy; read with the selected plan and prescribing decision. Checked September 22, 2026.
- HHS: Telehealth licensing across state linesUS government guidance · Licensure options depend on the patient location and state rules.
- FDA: Managing the benefits and risks of medicinesUS regulator · General questions for evaluating benefit, follow-up and new medicines.
- FDA: Compounding questions and answersUS regulator · Compounded medicines differ from FDA-approved generic drugs.
- RespondWell: Sermorelin shop offerProvider primary source · Provider offer; first-order and refill amounts differ from another RespondWell page. Checked September 22, 2026.